LeMaitre Vascular LMAT Accounts Receivable, Credit Loss Expense (Reversal)
Accounts Receivable, Credit Loss Expense (Reversal) at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about LeMaitre Vascular's accounts receivable, credit loss expense (reversal).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is LeMaitre Vascular's accounts receivable, credit loss expense (reversal)?
- LeMaitre Vascular (LMAT) reported accounts receivable, credit loss expense (reversal) of $0 in Q1 2026.
- How has LeMaitre Vascular's accounts receivable, credit loss expense (reversal) changed year-over-year?
- LeMaitre Vascular's accounts receivable, credit loss expense (reversal) decreased by 100.0% year-over-year, from $12K to $0.
- What is the long-term trend for LeMaitre Vascular's accounts receivable, credit loss expense (reversal)?
- Over 3 years (2022 to 2025), LeMaitre Vascular's accounts receivable, credit loss expense (reversal) has grown at a 8.6% compound annual growth rate (CAGR), from $637K to $817K.